Industry News
New cannabinoid compound to treat irritable bowel syndrome
Oxford Cannabinoid Technologies has announced the pre-clinical development of a new cannabinoid compound ‘OCT461201’ to treat IBS
News & Articles
25
Oxford Cannabinoid Technologies has announced the pre-clinical development of a new cannabinoid compound ‘OCT461201’ to treat IBS